questionText: To ask the Secretary of State for Health and Social Care, whether he plans to publish the methodology used by NHS England to calculate projected PET-CT activity volumes, including any assumptions relating to future demand growth and pathway developments in prostate cancer.
answerText: NHS England is responsible for commissioning prostate‑specific membrane antigen (PSMA) radiotracers for positron emission tomography–computed tomography (PET‑CT) imaging for adults with high‑risk primary or recurrent prostate cancer. The commissioning pol...
heading: Prostate Cancer: Screening